e-Drug3D

1137

DOXAPRAM


INN
DOXAPRAM

cas 309-29-5
CLASS

RESPIRATORY SYSTEM
RESPIRATORY STIMULANT
CENTRAL NERVOUS SYSTEM STIMULANTS

ROUTE (list)

INJECTION

ATC code

R07AB01

PK parameters

VD 78 LITER (65 KILOGRAM)
Cl 20 LITER / HOUR (65 KILOGRAM)
t1/2 4.1 HOUR

Solubility

SPARINGLY SOLUBLE IN WATER


Target

-

DrugCentral

Potassium channel subfamily K member 3 UNIPROT O14649 KCNK3

Potassium channel subfamily K member 9 UNIPROT Q9NPC2 KCNK9

Download SDF file 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-di(phenyl)pyrrolidin-2-one

Formula:
C24H30N2O2

Calculated chemical properties:

MW 378.50
NB_atoms 28
XLogP 3.17
PSA 33.858
NB_HD 0
NB_HA 4
fsp3 0.46
Lipinski(0=no;1=yes) 1

FDA
NDA 014879 (label) INN (DOXAPRAM HYDROCHLORIDE) DOPRAM (HIKMA) APPROVAL= AP YEAR= 1965
NDA 073529 (pdf not found) INN (DOXAPRAM HYDROCHLORIDE) DOXAPRAM HYDROCHLORIDE (WATSON LABS) APPROVAL= AP YEAR= 1992 DISCONTINUED
NDA 076266 (pdf not found) INN (DOXAPRAM HYDROCHLORIDE) DOXAPRAM HYDROCHLORIDE (CHARTWELL INJECTABLE) APPROVAL= AP YEAR= 2003

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL